-
Something wrong with this record ?
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
L. Prochazkova, DP. Lippelt, LS. Colzato, M. Kuchar, Z. Sjoerds, B. Hommel,
Language English Country Germany
Document type Clinical Trial, Phase I, Journal Article, Pragmatic Clinical Trial
NLK
ProQuest Central
from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1996-10-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 1997-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-02-01 to 1 year ago
Psychology Database (ProQuest)
from 1997-02-01 to 1 year ago
- MeSH
- Adult MeSH
- Hallucinogens administration & dosage MeSH
- Intelligence drug effects physiology MeSH
- Intelligence Tests MeSH
- Clinical Trials, Phase I as Topic MeSH
- Creativity * MeSH
- Humans MeSH
- Young Adult MeSH
- Motivation drug effects physiology MeSH
- Thinking drug effects physiology MeSH
- Nootropic Agents administration & dosage MeSH
- Problem Solving drug effects physiology MeSH
- Photic Stimulation methods MeSH
- Dose-Response Relationship, Drug MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial, Phase I MeSH
- Pragmatic Clinical Trial MeSH
INTRODUCTION: Taking microdoses (a mere fraction of normal doses) of psychedelic substances, such as truffles, recently gained popularity, as it allegedly has multiple beneficial effects including creativity and problem-solving performance, potentially through targeting serotonergic 5-HT2A receptors and promoting cognitive flexibility, crucial to creative thinking. Nevertheless, enhancing effects of microdosing remain anecdotal, and in the absence of quantitative research on microdosing psychedelics, it is impossible to draw definitive conclusions on that matter. Here, our main aim was to quantitatively explore the cognitive-enhancing potential of microdosing psychedelics in healthy adults. METHODS: During a microdosing event organized by the Dutch Psychedelic Society, we examined the effects of psychedelic truffles (which were later analyzed to quantify active psychedelic alkaloids) on two creativity-related problem-solving tasks: the Picture Concept Task assessing convergent thinking and the Alternative Uses Task assessing divergent thinking. A short version of the Ravens Progressive Matrices task assessed potential changes in fluid intelligence. We tested once before taking a microdose and once while the effects were expected to be manifested. RESULTS: We found that both convergent and divergent thinking performance was improved after a non-blinded microdose, whereas fluid intelligence was unaffected. CONCLUSION: While this study provides quantitative support for the cognitive-enhancing properties of microdosing psychedelics, future research has to confirm these preliminary findings in more rigorous placebo-controlled study designs. Based on these preliminary results, we speculate that psychedelics might affect cognitive metacontrol policies by optimizing the balance between cognitive persistence and flexibility. We hope this study will motivate future microdosing studies with more controlled designs to test this hypothesis.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012227
- 003
- CZ-PrNML
- 005
- 20190416110504.0
- 007
- ta
- 008
- 190405s2018 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00213-018-5049-7 $2 doi
- 035 __
- $a (PubMed)30357434
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Prochazkova, Luisa $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands. l.prochazkova@fsw.leidenuniv.nl.
- 245 10
- $a Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting / $c L. Prochazkova, DP. Lippelt, LS. Colzato, M. Kuchar, Z. Sjoerds, B. Hommel,
- 520 9_
- $a INTRODUCTION: Taking microdoses (a mere fraction of normal doses) of psychedelic substances, such as truffles, recently gained popularity, as it allegedly has multiple beneficial effects including creativity and problem-solving performance, potentially through targeting serotonergic 5-HT2A receptors and promoting cognitive flexibility, crucial to creative thinking. Nevertheless, enhancing effects of microdosing remain anecdotal, and in the absence of quantitative research on microdosing psychedelics, it is impossible to draw definitive conclusions on that matter. Here, our main aim was to quantitatively explore the cognitive-enhancing potential of microdosing psychedelics in healthy adults. METHODS: During a microdosing event organized by the Dutch Psychedelic Society, we examined the effects of psychedelic truffles (which were later analyzed to quantify active psychedelic alkaloids) on two creativity-related problem-solving tasks: the Picture Concept Task assessing convergent thinking and the Alternative Uses Task assessing divergent thinking. A short version of the Ravens Progressive Matrices task assessed potential changes in fluid intelligence. We tested once before taking a microdose and once while the effects were expected to be manifested. RESULTS: We found that both convergent and divergent thinking performance was improved after a non-blinded microdose, whereas fluid intelligence was unaffected. CONCLUSION: While this study provides quantitative support for the cognitive-enhancing properties of microdosing psychedelics, future research has to confirm these preliminary findings in more rigorous placebo-controlled study designs. Based on these preliminary results, we speculate that psychedelics might affect cognitive metacontrol policies by optimizing the balance between cognitive persistence and flexibility. We hope this study will motivate future microdosing studies with more controlled designs to test this hypothesis.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a klinické zkoušky, fáze I jako téma $7 D017321
- 650 12
- $a kreativita $7 D003405
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a halucinogeny $x aplikace a dávkování $7 D006213
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inteligence $x účinky léků $x fyziologie $7 D007360
- 650 _2
- $a inteligenční testy $7 D007361
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a motivace $x účinky léků $x fyziologie $7 D009042
- 650 _2
- $a nootropní látky $x aplikace a dávkování $7 D018697
- 650 _2
- $a světelná stimulace $x metody $7 D010775
- 650 _2
- $a řešení problému $x účinky léků $x fyziologie $7 D011340
- 650 _2
- $a myšlení $x účinky léků $x fyziologie $7 D013850
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a klinické zkoušky, fáze I $7 D017426
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pragmatická klinická studie $7 D065007
- 700 1_
- $a Lippelt, Dominique P $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
- 700 1_
- $a Colzato, Lorenza S $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands. Department of Cognitive Psychology, Institute of Cognitive Neuroscience, Faculty of Psychology, Ruhr University Bochum, Bochum, Germany. Institute for Sports and Sport Science, University of Kassel, Kassel, Germany.
- 700 1_
- $a Kuchar, Martin $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Prague, Czech Republic. Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic.
- 700 1_
- $a Sjoerds, Zsuzsika $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
- 700 1_
- $a Hommel, Bernhard $u Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
- 773 0_
- $w MED00003990 $t Psychopharmacology $x 1432-2072 $g Roč. 235, č. 12 (2018), s. 3401-3413
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30357434 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190416110529 $b ABA008
- 999 __
- $a ok $b bmc $g 1391537 $s 1050532
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 235 $c 12 $d 3401-3413 $e 20181025 $i 1432-2072 $m Psychopharmacology $n Psychopharmacology $x MED00003990
- LZP __
- $a Pubmed-20190405